Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations

ImmunotherapyT Cells

Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers

Clin Sci (Lond).

Inthagard J, Edwards J, Roseweir AK

doi: 10.1042/CS20181003.

Melanoma and Skin Cancer

A Bayesian Network Meta-analysis of Comparison of Cancer Therapeutic Vaccines for Melanoma

J Eur Acad Dermatol Venereol

Lau P, Shen M, Ma F, Chen Y, Zhang J, Su J, Chen X, Liu H

doi: 10.1111/jdv.17437

Immunotherapy

Recent progress in therapeutic antibodies for cancer immunotherapy

doi: 10.1016/j.cbpa.2018.05.006.

Melanoma and Skin Cancer

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

Lancet Oncol.

Turajlic S, Litchfield K, Xu H, Rosenthal R, McGranahan N, Reading JL, Wong YNS, Rowan A, Kanu N, Al Bakir M, Chambers T, Salgado R, Savas P, Loi S, Birkbak NJ, Sansregret L, Gore M, Larkin J, Quezada SA, Swanton C

doi: 10.1016/

Immunotherapy

The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy

Trends Cancer.

Rufo N, Garg AD, Agostinis P

doi: 10.1016/j.trecan.2017.07.002.

Melanoma and Skin CancerImmunotherapy

Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy

Biomaterials

Kim H, Niu L, Larson P, Kucaba TA, Murphy KA, James BR, Ferguson DM, Griffith TS, Panyam J

doi: 10.1016/j.biomaterials.

Melanoma and Skin Cancer

Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis

Int Immunopharmacol.

Caisová V, Uher O, Nedbalová P, Jochmanová I, Kvardová K, Masáková K, Krejčová G, Paďouková L, Chmelař J, Kopecký J, Ženka J

doi: 10.1016/

Immunotherapy

Immunooncology in Breast Cancer: Active and Passive Vaccination Strategies

Breast Care (Basel).

Schütz F, Marmé F, Domschke C, Sohn C, von Au A

doi: 10.1159/000486330.

Immune Response

Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals

Vaccine.

Burkhard J, Ciurea A, Gabay C, Hasler P, Müller R, Niedrig M, Fehr J, Villiger P, Visser LG, de Visser AW, Walker UA, Hatz C, Bühler S

doi: 10.1016/j.vaccine.2019.12.042.

Related content

Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers

A Bayesian Network Meta-analysis of Comparison of Cancer Therapeutic Vaccines for Melanoma

Recent progress in therapeutic antibodies for cancer immunotherapy

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy

Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy

Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis

Immunooncology in Breast Cancer: Active and Passive Vaccination Strategies

Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals